Cargando…

Optimizing the interval between administration of misonidazole and irradiation: an in vitro study.

Detalles Bibliográficos
Autores principales:	Hall, E. J., Astor, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1982
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011107/ https://www.ncbi.nlm.nih.gov/pubmed/7150477

Ejemplares similares

Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
por: Astor, M., et al.
Publicado: (1979)

In vitro metabolism of misonidazole.
por: Josephy, P. D., et al.
Publicado: (1981)

Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.
por: Miller, R. C., et al.
Publicado: (1978)

Oxygen dependence for chemosensitization by misonidazole.
por: Roizin-Towle, L., et al.
Publicado: (1986)

A phase I study of misonidazole and pelvic irradiation in patients with carcinoma of cervix.
por: Thomas, G. M., et al.
Publicado: (1982)

Studies with bleomycin and misonidazole on aerated and hypoxic cells.
por: Roizin-Towle, L., et al.
Publicado: (1978)

Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice.
por: Conroy, P. J., et al.
Publicado: (1980)

Bleomycin and misonidazole cytotoxicity.
por: Korbelik, M., et al.
Publicado: (1985)

Interactions between misonidazole and hyperthermia in EMT6 spheroids.
por: Morgan, J. E., et al.
Publicado: (1981)

Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro.
por: Stratford, I. J., et al.
Publicado: (1980)

Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
por: Taylor, Y. C., et al.
Publicado: (1980)

Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
por: Roizin-Towle, L. A., et al.
Publicado: (1981)

Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
por: Mulcahy, R. T., et al.
Publicado: (1984)

Chemopotentiation of CCNU metabolites by misonidazole.
por: Mulcahy, R. T.
Publicado: (1985)

Microscopic distribution of misonidazole in mouse tissues.
por: Cobb, L. M., et al.
Publicado: (1989)

Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985)

Split dose cytotoxic experiments with misonidazole.
por: Stratford, I. J.
Publicado: (1978)

The role of dexamethasone in the modification of misonidazole pharmacokinetics.
por: Jones, D. H., et al.
Publicado: (1983)

The penetration of misonidazole into spontaneous canine tumours.
por: White, R. A., et al.
Publicado: (1979)

Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
por: Durand, R. E., et al.
Publicado: (1987)

The quantitative response of human tumours to radiation and misonidazole.
por: Ash, D. V., et al.
Publicado: (1979)

Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
por: Honess, D. J., et al.
Publicado: (1980)

Cell-cycle inhibition by misonidazole of human cells cultivated in vitro under aerobic conditions.
por: Lindmo, T., et al.
Publicado: (1979)

In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.
por: Siemann, D. W., et al.
Publicado: (1984)

The penetration of misonidazole into a mature structural cartilage.
por: Langler, A. J., et al.
Publicado: (1982)

Peripheral electrophysiological parameters in mice treated with misonidazole.
por: Von Burg, R., et al.
Publicado: (1979)

Modulation of the hypoxic toxicity and binding of misonidazole by glucose.
por: Ling, L. L., et al.
Publicado: (1986)

Is tumour radiosensitization by misonidazole a general phenomenon?
por: Denekamp, J., et al.
Publicado: (1980)

Distribution of misonidazole in human tumours and normal tissues.
por: Ash, D. V., et al.
Publicado: (1979)

Effect of misonidazole on radiation injury to mouse spinal cord.
por: Travis, E. L., et al.
Publicado: (1982)

Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
por: Hirst, D. G., et al.
Publicado: (1982)

Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.
por: Clarke, C., et al.
Publicado: (1982)

In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
por: Siemann, D. W.
Publicado: (1981)

Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
por: Wheeler, K. T., et al.
Publicado: (1984)

Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.
por: McDermott, B. J., et al.
Publicado: (1983)

The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
por: Murray, J. C., et al.
Publicado: (1987)

Effect of local hyperthermia on the acute toxicity of misonidazole in mice.
por: Overgaard, J.
Publicado: (1979)

Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
por: Moore, J. L., et al.
Publicado: (1981)

Dependence of misonidazole binding on factors associated with hypoxic metabolism.
por: Ling, L. L., et al.
Publicado: (1987)

Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
por: Adams, G. E., et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_lqn3oqdlusfnp9odec5en3uk62